What is the typical adult dose of trazodone (an antidepressant medication) for depression and insomnia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adult Dose of Trazodone

For depression, start trazodone at 150 mg/day in divided doses and increase by 50 mg every 3-4 days up to 400 mg/day for outpatients (600 mg/day for inpatients), taken shortly after meals. 1

Depression Treatment Dosing

Initial Dosing

  • Begin at 150 mg/day in divided doses 1
  • Administer shortly after a meal or light snack to optimize absorption 1
  • If drowsiness occurs, shift the major portion of the daily dose to bedtime 1

Dose Titration

  • Increase by 50 mg/day every 3-4 days based on clinical response and tolerability 1
  • Outpatients: maximum 400 mg/day in divided doses 1
  • Inpatients (more severely depressed): up to 600 mg/day in divided doses 1

Alternative Dosing Strategy

  • Single nighttime dosing (150-300 mg at bedtime) is equally effective as divided doses for depression and produces better sleep with less daytime drowsiness during initial treatment. 2
  • This approach leverages trazodone's 3-9 hour half-life and is particularly useful when insomnia accompanies depression 2

Insomnia Treatment Dosing (Off-Label)

Low-Dose Regimen

  • The American Academy of Family Medicine recommends 25 mg at bedtime initially for insomnia, with a maximum of 200-400 mg/day in divided doses if needed 3
  • Lower doses (25-50 mg) are typically used for insomnia, which are below the therapeutic antidepressant range 4

Important Caveat About Insomnia Use

  • The American Academy of Sleep Medicine recommends against using trazodone for primary insomnia based on trials showing modest improvements that do not outweigh potential harms. 3, 4
  • Trazodone is considered only a third-line agent for insomnia, after cognitive behavioral therapy and benzodiazepine receptor agonists fail 4
  • It may be more appropriate when comorbid depression or anxiety is present 4

Special Populations

Elderly Patients

  • Lower starting doses are recommended due to increased risk of side effects, particularly orthostatic hypotension 3, 5
  • Maximum tolerated doses are typically 300-400 mg/day in elderly patients 5

Administration Details

Tablet Administration

  • Tablets can be swallowed whole or broken along the score line 1
  • Take shortly after meals to reduce side effects and optimize absorption 1

Drug Interactions Requiring Dose Adjustment

  • With strong CYP3A4 inhibitors: Consider reducing dose based on tolerability 1
  • With strong CYP3A4 inducers: Consider increasing dose based on therapeutic response 1

Safety Considerations

Contraindications and Precautions

  • Screen for bipolar disorder, mania, or hypomania before initiating treatment 1
  • Allow at least 14 days between discontinuing an MAOI and starting trazodone (and vice versa) 1
  • Use with caution in patients with premature ventricular contractions 3
  • Monitor for orthostatic hypotension, especially in cardiovascular disease and elderly patients 6

Discontinuation

  • Taper gradually over 10-14 days rather than stopping abruptly to limit withdrawal symptoms 3, 1
  • Reduce dosage gradually once adequate response is achieved 1

Common Adverse Effects

  • Most common: somnolence, headache, dizziness, and dry mouth 6
  • Dose-dependent drowsiness is the most frequent side effect 7
  • Rare but serious: priapism, cardiac arrhythmias, QT prolongation 6, 5
  • Notably lower anticholinergic and cardiovascular effects compared to tricyclic antidepressants 5

References

Research

Trazodone dosing regimen: experience with single daily administration.

The Journal of clinical psychiatry, 1990

Guideline

Trazodone Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Trazodone for Insomnia Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Trazodone for Insomnia: A Systematic Review.

Innovations in clinical neuroscience, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.